Cargando…
Primary IgA nephropathy: current challenges and future prospects
IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis worldwide, exhibiting a variable clinical and pathological course and significantly contributing to the global burden of chronic kidney disease and end-stage renal disease. Current standards of care focus on optimization of...
Autores principales: | Penfold, Rose S, Prendecki, Maria, McAdoo, Stephen, Tam, Frederick WK |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905843/ https://www.ncbi.nlm.nih.gov/pubmed/29695925 http://dx.doi.org/10.2147/IJNRD.S129227 |
Ejemplares similares
-
Role of the Spleen Tyrosine Kinase Pathway in Driving Inflammation in IgA Nephropathy
por: McAdoo, Stephen, et al.
Publicado: (2018) -
Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023) -
Current treatment of IgA nephropathy
por: Floege, Jürgen, et al.
Publicado: (2021) -
Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019) -
COVID-19 vaccination in patients with immunity-mediated kidney disease
por: Prendecki, Maria, et al.
Publicado: (2021)